ZSCAN12P1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.483800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.906000E-01
Normal-vs-Stage2
8.233000E-01
Normal-vs-Stage3
7.107600E-02
Normal-vs-Stage4
9.111600E-01
Stage1-vs-Stage2
8.602400E-01
Stage1-vs-Stage3
2.083000E-01
Stage1-vs-Stage4
5.675800E-01
Stage2-vs-Stage3
2.271800E-01
Stage2-vs-Stage4
7.280400E-01
Stage3-vs-Stage4
2.731500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.846000E-01
Normal-vs-AfricanAmerican
4.261200E-01
Normal-vs-Asian
9.036200E-01
Caucasian-vs-AfricanAmerican
8.420200E-02
Caucasian-vs-Asian
8.608600E-01
AfricanAmerican-vs-Asian
4.499000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.232800E-01
Normal-vs-Female
8.721400E-01
Male-vs-Female
4.043000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.457800E-01
Normal-vs-Age(41-60Yrs)
9.735800E-01
Normal-vs-Age(61-80Yrs)
7.015600E-01
Normal-vs-Age(81-100Yrs)
9.311800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.412400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.712200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.901200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.388580E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.918800E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.497700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.070100E-02
Normal-vs-Daily Drinker
2.029800E-01
Normal-vs-Weekly Drinker
9.685200E-01
Normal-vs-Occasional Drinker
3.954600E-01
Normal-vs-Social Drinker
8.087200E-01
Non Drinker-vs-Daily Drinker
5.040400E-01
Non Drinker-vs-Weekly Drinker
7.179500E-02
Non Drinker-vs-Occasional Drinker
3.378400E-01
Non Drinker-vs-Social Drinker
3.106300E-02
Daily Drinker-vs-Weekly Drinker
1.398820E-01
Daily Drinker-vs-Occasional Drinker
6.744600E-01
Daily Drinker-vs-Social Drinker
6.483700E-02
Weekly Drinker-vs-Occasional Drinker
2.161200E-01
Weekly Drinker-vs-Social Drinker
7.328000E-01
Occasional Drinker-vs-Social Drinker
1.050240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.871010E-01
Normal-vs-Grade 2
9.403500E-02
Normal-vs-Grade 3
1.014800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.100600E-01
Grade 1-vs-Grade 3
9.574600E-01
Grade 1-vs-Grade 4
1.871010E-01
Grade 2-vs-Grade 3
1.049770E-01
Grade 2-vs-Grade 4
9.403500E-02
Grade 3-vs-Grade 4
1.014800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.253410E-01
Normal-vs-NonDiabetic
8.090800E-01
Diabetic-vs-NonDiabetic
5.495700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.190800E-01
Normal-vs-NoPancreatitis
6.754600E-01
Pancreatitis-vs-NoPancreatitis
9.789600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.366000E-01
Normal-vs-N1
8.263800E-01
N0-vs-N1
3.102200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.817400E-01
Normal-vs-TP53-NonMutant
8.547600E-01
TP53-Mutant-vs-TP53-NonMutant
9.538800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
